Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience

Background Sympathetic nerve activity is a hallmark of hypertension in end-stage renal disease (ESRD). An initial proof-of-concept study implies that renal denervation (RDN) is feasible and safe in RDN, but overall data are limited.